Northland Securities analyst Owen Rickert maintained a Buy rating on Owlet today and set a price target of $15.50.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Owen Rickert has given his Buy rating due to a combination of factors that highlight Owlet’s strong performance and promising future. The company has surpassed expectations in 2025, driven by impressive sales of its Dream Sock and Dream Duo products globally, along with significant adoption of Owlet 360 in the US. This momentum is expected to continue as Owlet rolls out its first international subscription offering in key markets and plans further expansion in 2026.
Rickert is particularly optimistic about Owlet’s strategic shift towards a subscription-based model, supported by increased R&D investments. The company is poised to benefit from favorable market conditions, including regulatory approvals and a competitive edge due to recent FDA warnings against competitors. Additionally, the partnership with Rhapsody and the upcoming telehealth offerings are expected to contribute to Owlet’s growth trajectory, making it a compelling investment opportunity for the future.